Thermo Fisher wins FDA clearance for MRSA test medium

With the highest positive predictive value commercially available for methicillin-resistant Staphylococcus aureus (MRSA) screening, Spectra is said to provide accurate results within 24 hours. The Spectra MRSA test is manufactured, distributed and sold under the Thermo Fisher specialty brand, Remel.

Spectra MRSA is a ready-to-use, labor-saving test easily adopted in any healthcare facility to enable continuous testing of patients. The test medium is easy to read, with MRSA appearing as distinctive dark blue colonies. Its use can help to simplify MRSA screening programs, allowing patient testing 24 hours a day, seven days a week.

Marijn Dekkers, president and CEO of Thermo Fisher Scientific, said: “Spectra MRSA offers healthcare facilities a high-performance solution that integrates with routine laboratory workflows, enabling them to take a more proactive approach to patient care and safety.”